Cardiotoxicity clinical trials
The registry lists 263 studies for Cardiotoxicity across more than 10 countries. 73 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 94
- Recruiting
- 55
- Status unknown
- 54
- Terminated
- 24
- Active, not recruiting
- 15
- Not yet recruiting
- 13
Phase
- Phase 2
- 32
- Phase 3
- 27
- Phase 4
- 10
- Phase 1
- 9
- Early Phase 1
- 2
Where
- United States
- 78
- Canada
- 30
- China
- 18
- France
- 16
- Italy
- 15
- United Kingdom
- 12
Who runs them
Abramson Cancer Center at Penn Medicine (11) · Memorial Sloan Kettering Cancer Center (6) · Children's Oncology Group (5) · University Health Network, Toronto (5) · University College, London (5) · Ain Shams University (4) · Tanta University (4) · Peking University Third Hospital (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 263 — search for more.
- Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced CardiotoxicityNot yet recruitingNCT07838649Phase 11 country
- Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell LymphomaRecruitingNCT06220032Phase 31 country
- Cardiac Side Effects of Systemic Therapy in Early-Stage Breast CancerRecruitingNCT075884251 country
- Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07761910Phase 21 country
- Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine CareRecruitingNCT038825801 country
- Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE)Not yet recruitingNCT07776964Not applicable1 country
- TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by EchocardiographyRecruitingNCT06310330Not applicable1 country
- The CARDIOPROTECT TrialRecruitingNCT07654426Phase 21 country
- The STOP-MED CTRCD TrialRecruitingNCT06183437Phase 46 countries
- Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac DysfunctionRecruitingNCT03934905Phase 1/21 country
- Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.RecruitingNCT076633571 country
- JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First YearRecruitingNCT06930521Not applicable1 country
- Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer PatientsRecruitingNCT027723671 country
- AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable MonitorRecruitingNCT066990561 country
- Cardiac Dysfunction in Childhood Cancer SurvivorsRecruitingNCT037909431 country
- Novel On-body Evaluation of Cardiac Health for OncologyEnrolling by invitationNCT071584501 country
- A Study of Blood Pressure Control During Cancer TreatmentRecruitingNCT06023576Phase 21 country
- Global Cardio Oncology RegistryRecruitingNCT055988791 country
- Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityNot yet recruitingNCT07572175Phase 21 country
- Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer TherapyRecruitingNCT07528586Not applicable1 country
- Hypertension and Arrhythmias in CLL Patients Treated With BTK InhibitorsEnrolling by invitationNCT062114131 country
- ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted TherapiesRecruitingNCT071917301 country
- Artificial Intelligence for Reconstruction of Echocardiography StudiesNot yet recruitingNCT07093918
- Effects of Immune Checkpoint Inhibitors on Coronary MicrovasculatureEnrolling by invitationNCT063321311 country
- Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-BRecruitingNCT064436451 country
- Early Identification of Cardivascular Damage Induced by Chemotherapy and Antineoplastic Treatments in Pediatric AgeRecruitingNCT07382141Not applicable1 country
- Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER StudyRecruitingNCT06595147Not applicable1 country
- BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEARTRecruitingNCT072998121 country
- Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer PatientsNot yet recruitingNCT07254221Phase 41 country
- The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled TrialRecruitingNCT05023785Not applicable1 country
- Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedRecruitingNCT05559164Phase 21 country
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility StudyNot yet recruitingNCT053773201 country
- S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityRecruitingNCT03418961Phase 34 countries
- CARDiac Toxicity Following ImmunOtherapy Treatment for MelanomaEnrolling by invitationNCT066058331 country
- Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Not yet recruitingNCT07157670
- Early Assessment of Cardiac Function After Treatment With CAR-T CellsRecruitingNCT063509941 country
- Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related CardiotoxicityRecruitingNCT061329841 country
- Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort StudyNot yet recruitingNCT068971891 country
- Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast CancerRecruitingNCT05406635Not applicable1 country
- Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)RecruitingNCT03711110Not applicable1 country
- Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or TrastuzumabNot yet recruitingNCT06881940Not applicable1 country
- Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)RecruitingNCT05465031Phase 41 country
- Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic TherapiesRecruitingNCT066645281 country
- Cardioprotection on Chemotherapy-Induced CardiotoxicityRecruitingNCT06853951Phase 31 country
- Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart FailureRecruitingNCT042628301 country
- Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With AnthracyclinesRecruitingNCT067743261 country
- Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity StudyEnrolling by invitationNCT042602697 countries
- Effects of Lurasidone on Left Ventricle Systolic FunctionsNot yet recruitingNCT066956761 country
- Atorvaststin and Cardiotoxicity in Acute Myloid LeukemiaNot yet recruitingNCT06684509Phase 1/21 country
- Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AMLRecruitingNCT05703126Not applicable1 country